Yue Gong

机构：Fudan University Shanghai Cancer Center · ORCID：0000-0002-6842-5318

发表论文 73 篇 · 总被引 4307 次 · h-index 22

代表论文

• Comprehensive metabolomics expands precision medicine for triple-negative breast cancer (2022 · Cell Research · 被引 328)
• DeepSeek-V3 Technical Report (2024 · arXiv (Cornell University) · 被引 257)
• Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential (2024 · Signal Transduction and Targeted Therapy · 被引 198)
• Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy (2022 · Journal of Hematology & Oncology · 被引 191)
• In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer (2022 · Science Advances · 被引 85)
• Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial (2024 · BMJ · 被引 15)